Skip to main content
Clinical Trials/RBR-4qmypqq
RBR-4qmypqqNot yet recruitingPhase 4

Randomized open-label and non-inferiority clinical trial to evaluate treatment retention, safety and cost-effectiveness of simplified and decentralized HCV treament compared to standard-of-care in the brazilian public health system

Fundação Oswaldo Cruz0 sitesStarted: October 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Intervention

Eligibility Criteria

Ages
18Y to 79Y (—)

Inclusion Criteria

  • Age between18 and 79 years-old; presence of chronic hepatitis C

Exclusion Criteria

  • Pregnancy; HBV co-infection; HIV co-infection; use of medications with potential interaction with SOF/VEL; presence of acute disease, neoplasm, solid organ transplant or use of immunossupressor; presence of clinical signs of decompensated cirrhosis; refusal to participate

Investigators

Similar Trials